121 related articles for article (PubMed ID: 171574)
1. Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Jain AK; Ryan JR; McMahon FG
N Engl J Med; 1975 Dec; 293(25):1283-6. PubMed ID: 171574
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Kudzma DJ; Friedberg SJ
Diabetes; 1977 Apr; 26(4):291-5. PubMed ID: 321288
[TBL] [Abstract][Full Text] [Related]
3. The metabolic spectrum of halofenate.
Ryan JR
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):239-43. PubMed ID: 51838
[TBL] [Abstract][Full Text] [Related]
4. One-year trials with halofenate, clofibrate, and placebo.
Dujovne CA; Azarnoff DL; Huffman DH; Pentikäinen P; Hurwitz A; Shoeman DW
Clin Pharmacol Ther; 1976 Mar; 19(3):352-9. PubMed ID: 177242
[TBL] [Abstract][Full Text] [Related]
5. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
Pedrazzi F; Bommartini F; Freddo J; Emanueli A
Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
[No Abstract] [Full Text] [Related]
7. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
Krut LH; Seftel HC; Joffe BI
S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994
[TBL] [Abstract][Full Text] [Related]
8. Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia.
Feldman EB; Gluck FB; Carter AC
J Clin Pharmacol; 1978; 18(5-6):241-8. PubMed ID: 346616
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
Keller C; Wolfram G; Zöllner N
Arzneimittelforschung; 1976; 26(12):2221-4. PubMed ID: 798591
[TBL] [Abstract][Full Text] [Related]
10. A two-year crossover therapeutic trial with halofenate and clofibrate.
Dujovne CA; Azarnoff DL; Pentikainen P; Manion C; Hurwitz A; Hassanein K
Am J Med Sci; 1976; 272(3):277-84. PubMed ID: 797258
[TBL] [Abstract][Full Text] [Related]
11. Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
Rees ED; Hamilton RD; Kanner IF; Wasson S; Hearn T
Atherosclerosis; 1976 Sep; 24(3):537-46. PubMed ID: 788722
[TBL] [Abstract][Full Text] [Related]
12. [Effect of halofenate on triglyceride and uric acid levels, coagulation and platelet behaviour in patients with hyperlipoproteinemia type IV and hyperuricemia (author's transl)].
Kuntzen O; Hehl FJ; Walter E; Zimmermann R
Arzneimittelforschung; 1978; 28(12):2349-52. PubMed ID: 227420
[TBL] [Abstract][Full Text] [Related]
13. Halofenate versus clofibrate in the management of true diabetes insipidus.
Gattereau A; Davignon J; Verdy M; Lewis W
Can Med Assoc J; 1974 Jun; 110(11):1275-77. PubMed ID: 4834432
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients.
Lisch HJ; Patsch J; Sailer S; Braunsteiner H
Atherosclerosis; 1975; 21(3):391-9. PubMed ID: 1148032
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Schapel GJ; Edwards KD
J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221
[TBL] [Abstract][Full Text] [Related]
17. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
Jung W; Kremer GJ; Müller D
MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
19. A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia.
Rottiers R; van Egmond J
Acta Clin Belg; 1975; 30(5):398-408. PubMed ID: 1221746
[No Abstract] [Full Text] [Related]
20. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M
Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
